What is the ticker symbol for 4D pharma?

4D pharma trades under the ticker LBPSW on NASDAQ.

What sector does 4D pharma operate in?

4D pharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LBPSW in a portfolio?

PortView shows LBPSW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

4D pharma (LBPSW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.04+14.81%

1-year price historyRange $0.04 – $0.95

52-week range$0.04

$0.04$1.00

What 4D pharma does

4D pharma plc, together with its affiliated entities, specializes in the research, development, and manufacturing of live biotherapeutic products (LBPs). The company's diverse pipeline features key therapeutic candidates such as Blautix for irritable bowel syndrome (IBS) and Thetanix, targeting pediatric Crohn's disease. In immuno-oncology, the company is advancing MRx0518, MRx0573, and MRx1299 for various solid tumors, with MRx0518 specifically also being developed for pancreatic cancer. Other notable developments include respiratory therapies like MRx-4DP0004 for asthma and COVID-19, as well as central nervous system (CNS) treatments, MRx0005 and MRx0029, for neurodegenerative conditions. Beyond specific drug candidates, 4D pharma plc's platform technologies extend to vaccines and autoimmune disorders. The firm has established a strategic collaboration with Merck & Co., Inc. to conduct a clinical trial. This study is designed to assess the efficacy of combining Merck's Keytruda with 4D pharma's MRx0518 in patients battling solid tumors. Founded in Leeds, United Kingdom, in 2014, the company was originally incorporated under the name Schosween 18 Limited.

Key metrics

Market cap

P/E (TTM)

0.00

Beta

0.00

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$0.00

200-day avg

$0.00

52-week high

$1.00

52-week low

$0.04

CEO

Duncan Joseph Peyton

ETFs linked to LBPSW

Broad-market and Healthcare sector ETFs an investor holding 4D pharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how LBPSW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LBPSW in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for 4D pharma?: 4D pharma trades under the ticker LBPSW on NASDAQ.
Which exchange is LBPSW listed on?: LBPSW is listed on NASDAQ.
What sector does 4D pharma operate in?: 4D pharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze LBPSW in a portfolio?: PortView shows LBPSW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.